ETF overview
The Global X Russell 2000 Covered Call ETF, identified by its ticker RYLD, aims to replicate the total return—encompassing both price appreciation and income generation—of the Cboe Russell 2000 BuyWrite Index. This objective is measured before accounting for the ETF's own associated fees and operational expenses.
Fund facts
- Expense ratio
- 0.60%
- Fund assets
- 1.29B USD (all share classes)
- Issuer
- Global X
- Inception date
- Apr 17, 2019
- Number of holdings
- 8
Breakdown
Holdings (8)
| Name | Ticker | Weight |
|---|---|---|
| GLOBAL X RUSSELL 2000 ETF | RSSL | 100.04% |
| INHIBRX INC | 0.00% | |
| NOVARTIS AG - CVR | 0.00% | |
| CARTESIAN THERAPEUTICS INC | 0.00% | |
| OMNIAB INC - 12.5 EARNOUT | 0.00% | |
| RAIN ONCOLOGY INC | RAIN | 0.00% |
| OMNIAB INC - 15.00 EARNOUT | 0.00% | |
| RUT US 10/16/26 C2855 | -0.10% |
Historical returns do not guarantee future returns. This is not investment advice.
- Expense ratio
- 0.60%
- Fund assets
- 1.29B USD (all share classes)
- Issuer
- Global X
- Inception date
- Apr 17, 2019
- Number of holdings
- 8
| Name | Ticker | Weight |
|---|---|---|
| GLOBAL X RUSSELL 2000 ETF | RSSL | 100.04% |
| INHIBRX INC | 0.00% | |
| NOVARTIS AG - CVR | 0.00% | |
| CARTESIAN THERAPEUTICS INC | 0.00% | |
| OMNIAB INC - 12.5 EARNOUT | 0.00% | |
| RAIN ONCOLOGY INC | RAIN | 0.00% |
| OMNIAB INC - 15.00 EARNOUT | 0.00% | |
| RUT US 10/16/26 C2855 | -0.10% |
The Global X Russell 2000 Covered Call ETF, identified by its ticker RYLD, aims to replicate the total return—encompassing both price appreciation and income generation—of the Cboe Russell 2000 BuyWrite Index. This objective is measured before accounting for the ETF's own associated fees and operational expenses.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free